News for 'Data Scientist'

'This is an unprecedented opportunity to upskill'

'This is an unprecedented opportunity to upskill'

Rediff.com15 Apr 2020

'What has gained prominence are 'human' skills like creativity, originality and initiative, critical thinking, persuasion, and negotiation, as well as attention to detail, resilience, flexibility and complex problem-solving.'

India administers over 100 crore anti-Covid jabs

India administers over 100 crore anti-Covid jabs

Rediff.com21 Oct 2021

The prime minister also visited the Ram Manohar Lohia Hospital in New Delhi after the milestone was achieved and interacted with hospital officials.

Hotter weather affects survival of coronavirus on surfaces

Hotter weather affects survival of coronavirus on surfaces

Rediff.com11 Jun 2020

The researchers said the growth rate of COVID-19 is weakly linked to the outdoor weather, adding that the chances of the survival of the virus "increases roughly by five times under a humid condition as compared to a dry condition."

The Nobels and the Age Problem

The Nobels and the Age Problem

Rediff.com22 Oct 2020

Science is a young person's game. An award to a young scientist could free up that person to do productive work, or help win more grants by enhancing reputation, argues Devangshu Datta.

With Omicron, 3rd wave projected to hit India by Feb

With Omicron, 3rd wave projected to hit India by Feb

Rediff.com6 Dec 2021

With Omicron, the new variant of SARS-CoV2, the third wave of coronavirus could hit the peak by February with cases likely to be reaching up to 1-1.5 lakh a day in the country, but it will be milder than the second wave, Manindra Agarwal, IIT scientist involved in the mathematical projection of trajectory of COVID-19, said.

'Covid vaccine will be equally effective against new mutant'

'Covid vaccine will be equally effective against new mutant'

Rediff.com21 Dec 2020

The CSIR DG said the transmissibility of the new strain N501Y is a "bit higher" but this does not mean it is more lethal and more people are going to die due to it.

Shopping 3.0 is here

Shopping 3.0 is here

Rediff.com12 Dec 2017

Turbocharged with technology is becoming the Holy Grail of retail.

When did vying for attention become so evil?

When did vying for attention become so evil?

Rediff.com31 Oct 2020

The Social Dilemma shows how social media is turning human beings into lab rats and zombies, notes Chintan Girish Modi.

Covid: Big 3rd wave unlikely in India, say experts

Covid: Big 3rd wave unlikely in India, say experts

Rediff.com23 Nov 2021

Is the worst of the Covid crisis behind India? As cases dip three weeks after Diwali, the answer is a possible yes, say several experts, attributing the downslide to a large section of the population already exposed to the virus during the second wave and a stepped up vaccination campaign.

'GM Mustard Must Be Uprooted And Burnt'

'GM Mustard Must Be Uprooted And Burnt'

Rediff.com9 Dec 2022

'Why should our government opt for unproven technology that has been rejected by most countries across the globe?' 'Being dependent on any other nation to supply you seed for your good crops is another form of slavery.'

Breakthrough Covid infections in India within expected numbers: INSACOG

Breakthrough Covid infections in India within expected numbers: INSACOG

Rediff.com1 Sep 2021

When a person gets an infection even after being vaccinated against it, it is called a breakthrough case.

Expert panel recommends granting emergency nod to Oxford vaccine

Expert panel recommends granting emergency nod to Oxford vaccine

Rediff.com2 Jan 2021

As for Bharat Biotech, the Subject Expert Committee (SEC) on COVID-19 of the CDSCO asked the firm to expedite volunteer recruitment for the ongoing clinical trial and said it may conduct interim efficacy analysis for further consideration of restricted emergency use approval for its vaccine Covaxin, they stated.

Congress raises 'Chinese surveillance' issue in RS

Congress raises 'Chinese surveillance' issue in RS

Rediff.com16 Sep 2020

The Chinese company has also collected the data base of bureaucrats in key positions, judges, scientists, academicians, journalists, actors, sportspersons, religious figures and activists, he added.

It will take India 600 days to vaccinate 1 billion people

It will take India 600 days to vaccinate 1 billion people

Rediff.com15 Apr 2021

The data gaps are inhibiting sound decisions. We need to know seroprevalence, infection, and vaccination rates. This is required in 200 cities of India, every week, suggests Ajay Shah.

Study says coronavirus infects heart cells of patients

Study says coronavirus infects heart cells of patients

Rediff.com1 Jul 2020

"We not only uncovered that these stem cell-derived heart cells are susceptible to infection by novel coronavirus, but that the virus can also quickly divide within the heart muscle cells," said study co-author Arun Sharma from the Cedars-Sinai Board of Governors Regenerative Medicine Institute in the United States. "Even more significant, the infected heart cells showed changes in their ability to beat after 72 hours of infection," Sharma said.

PM Modi gives tight hug to emotional ISRO chief

PM Modi gives tight hug to emotional ISRO chief

Rediff.com7 Sep 2019

Modi, in his address at the ISRO centre asked the scientists not to get disheartened by the hurdles in the lunar mission Chandrayaan-2 and asserted that there will be a "new dawn".

Covaxin shows 78% efficacy in phase-3 interim analysis

Covaxin shows 78% efficacy in phase-3 interim analysis

Rediff.com21 Apr 2021

Safety and Efficacy results from the final analysis will be available in June, and the final report will be submitted to a peer-reviewed publication.

Omicron: 'Vaccine immunity may be less effective'

Omicron: 'Vaccine immunity may be less effective'

Rediff.com7 Dec 2021

'Antiviral treatment will have no change. Spike protein change may affect the immunity protection.'

Covishield, Covaxin effective against 'Indian strain' of Covid, study suggests

Covishield, Covaxin effective against 'Indian strain' of Covid, study suggests

Rediff.com27 Apr 2021

Anurag Agrawal, the Director of the Institute of Genomics and Integrative Biology, said the study on effectiveness of the available vaccines on the B.1.617 variant of SARS-CoV2 suggests that post vaccination, the infections are milder.

Amid Omicron surge, new Covid variant 'IUH' found in France

Amid Omicron surge, new Covid variant 'IUH' found in France

Rediff.com4 Jan 2022

The B.1.640.2 variant has been reported by researchers at institute IHU Mediterranee Infection in at least 12 cases, and has been linked to travel to African country Cameroon.

India's excess Covid deaths may be between 3.4- 4.9mn: Study

India's excess Covid deaths may be between 3.4- 4.9mn: Study

Rediff.com21 Jul 2021

India's official COVID-19 tally on Wednesday was 4,18,480 (4.18 lakh), the third highest in the world after the US and Brazil.

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Rediff.com29 Dec 2020

The Serum Institute of India has stockpiled 40 mn-50 mn doses and is adding more every week. Most of these will come to India.

Does India need booster shots to fight Omicron?

Does India need booster shots to fight Omicron?

Rediff.com12 Dec 2021

'Better to prevent than to wait for evidence. Protection delayed can also mean protection denied'

India's 3rd Covid wave likely to peak on Jan 23: IIT prof

India's 3rd Covid wave likely to peak on Jan 23: IIT prof

Rediff.com19 Jan 2022

Delhi, Mumbai and Kolkata have already reached their peak in case numbers in the past seven days, said Manindra Agrawal, a professor at IIT Kanpur and one of the researchers associated with the Sutra Covid model.

Can Nykaa teach Amazon, Flipkart a lesson?

Can Nykaa teach Amazon, Flipkart a lesson?

Rediff.com7 Aug 2017

Unlike some of India's largest online retailers like Flipkart, Amazon, Myntra and Jabong, which are very secretive about their data and use it to cut better deals with brands than their competitors, the Nykaa monetising its insights. If it is is able to do so without giving away any of its advantages to competitors, it could be on to a winning model.

Covid vaccine: Too early to say if booster dose needed

Covid vaccine: Too early to say if booster dose needed

Rediff.com30 Apr 2021

Initial data has shown immunity triggered by the two mRNA vaccines -- Pfizer-BioNTech and Moderna -- lasts for at least six months

IMA requests its 3.5 lakh members to voluntarily get vaccinated

IMA requests its 3.5 lakh members to voluntarily get vaccinated

Rediff.com11 Jan 2021

"The Indian Medical Association has requested all its 3.5 lakh members in 1,800 local branches to voluntarily come out to get vaccinated first to show the world that these vaccines are safe and efficacious," it said.

COVID-19: Prominent Indian-origin virologist dies in South Africa

COVID-19: Prominent Indian-origin virologist dies in South Africa

Rediff.com1 Apr 2020

Gita Ramjee has become the first Indian-origin South African to have died after contracting the novel coronavirus. Ramjee, a stellar vaccine scientist and an HIV prevention research leader, had returned from London a week ago but reportedly showed no symptoms of COVID-19.

Phase II trial finds Chinese COVID-19 vaccine is safe

Phase II trial finds Chinese COVID-19 vaccine is safe

Rediff.com21 Jul 2020

Since the trial participants were not exposed to the coronavirus after vaccination, the scientists said it is not possible for the current study to determine the efficacy of the candidate vaccine.

G7 leaders discuss Wuhan lab leak theory behind Covid

G7 leaders discuss Wuhan lab leak theory behind Covid

Rediff.com13 Jun 2021

World leaders gathered at the G7 Summit in Cornwall discussed the possibility that a laboratory leak in central China's Wuhan city may have a connection with the start of the COVID-19 pandemic, with the World Health Organisation (WHO) chief saying all hypotheses behind the origins of the deadly disease remain in play.

Not yet clear if Omicron more transmissible: WHO

Not yet clear if Omicron more transmissible: WHO

Rediff.com29 Nov 2021

The World Health Organisation has said it is 'not yet clear' whether the newly-detected coronavirus variant Omicron is more transmissible or causes more severe disease compared to other variants, including the highly-transmissible and globally prevalent Delta variant.

Coronavirus hits children less severely than adults, says study

Coronavirus hits children less severely than adults, says study

Rediff.com14 Mar 2020

'However, the importance of children in transmitting the virus remains uncertain,' the scientists cautioned in the study. 'Coronaviruses are a large family of viruses that can cause infection and disease in animals, capable of rapid mutation and recombination, leading to novel viruses that can spread from animals to humans,' they said.

India readies 5 sites for final phase of trials of Oxford COVID vaccine

India readies 5 sites for final phase of trials of Oxford COVID vaccine

Rediff.com28 Jul 2020

The Serum Institute of India, the largest vaccine maker in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it is ready. Trials results for the first two phases were published earlier this month.

2021: How Covid kept the world on tenterhooks, with surprises aplenty

2021: How Covid kept the world on tenterhooks, with surprises aplenty

Rediff.com29 Dec 2021

As the Omicron strain spreads across the globe and questions on vaccine inequity dominate discussions, scientists are still scrambling to learn more about emerging variants of the deadly virus that has claimed millions of lives and crippled economies.

Omicron evades vaccine, antibody therapies: Study

Omicron evades vaccine, antibody therapies: Study

Rediff.com24 Dec 2021

Omicron can evade the immune protection conferred by COVID-19 vaccines and natural infection, according to a peer-reviewed study which also suggests that the new variant of coronavirus is completely resistant to antibody therapies in use today.

PM directs full preparedness for vaccine distribution

PM directs full preparedness for vaccine distribution

Rediff.com17 Oct 2020

In a statement, the PMO said three vaccines are in advanced stages of development in India, out of which two are in Phase II and one is in Phase-III. It further said Indian Scientists and research teams are collaborating and strengthening the research capacities in neighbouring countries such as Afghanistan, Bhutan, Bangladesh, Maldives, Mauritius, Nepal and Sri Lanka.

US intel says Covid not a bio-weapon, unsure about its origins

US intel says Covid not a bio-weapon, unsure about its origins

Rediff.com28 Aug 2021

The United States intelligence community has failed to reach any firm conclusion on the exact origin of COVID-19 and is split on whether it leaked from a lab in China or emerged in nature, even though it does not believe the virus was developed as a biological weapon, according to results of a detailed review ordered by President Joe Biden.

1 in 4 experience mild side effects from Covishield: Lancet study

1 in 4 experience mild side effects from Covishield: Lancet study

Rediff.com28 Apr 2021

The researchers from King's College London in the United Kingdom also found that most systemic side effects -- meaning side effects excluding where the injection took place -- peaked within the first 24 hours following vaccination and usually lasted 1-2 days.

Can depression be traced back to your genes?

Can depression be traced back to your genes?

Rediff.com19 Apr 2018

A new research has pinpointed some genes that can trigger depression.

NASA/ESA spacecraft to give first images of Sun's poles

NASA/ESA spacecraft to give first images of Sun's poles

Rediff.com10 Feb 2020

Solar Orbiter is on a unique trajectory that will allow its comprehensive set of instruments to provide humanity with the first-ever images of the Sun's poles, the US space agency said. This trajectory includes 22 close approaches to the Sun, bringing the spacecraft within the orbit of Mercury to study the Sun, and its influence on space, it said.